Cannara Biotech Inc.
LOVFF
$1.34
-$0.02-1.47%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 182.88% | 109.88% | -28.60% | -9.91% | 6.93% |
| Total Depreciation and Amortization | 2.25% | 11.34% | 15.68% | 27.19% | 22.49% |
| Total Amortization of Deferred Charges | -65.08% | -65.08% | -79.77% | -92.29% | 37.00% |
| Total Other Non-Cash Items | -84.79% | -181.56% | 390.93% | 175.27% | 1,342.19% |
| Change in Net Operating Assets | 51.93% | 14.05% | 128.94% | 65.43% | 63.91% |
| Cash from Operations | 84.08% | 19.35% | 141.19% | 99.05% | 1,601.49% |
| Capital Expenditure | 40.57% | 25.68% | 33.47% | 25.15% | 33.41% |
| Sale of Property, Plant, and Equipment | -98.66% | 1,618.27% | 1,080.82% | 994.43% | 2,591.91% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.59% | 20.39% | -9.64% | -23.32% | -10.78% |
| Cash from Investing | 22.12% | 51.79% | 57.40% | 45.77% | 50.48% |
| Total Debt Issued | -93.06% | -58.46% | -32.73% | 90.00% | -82.36% |
| Total Debt Repaid | 35.00% | -98.67% | -115.95% | -107.99% | 80.43% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 100.00% | 100.00% | 99.34% | 25.99% | -180.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 25.13% | 42.57% | 21.93% | -1.73% | -39.29% |
| Cash from Financing | -104.91% | -135.73% | -114.59% | 7.68% | -120.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 510.47% | 314.47% | 283.40% | 129.71% | 171.46% |